Offering pharmacy professionals insights into the benefits, importance and challenges associated with switching patients to long-acting injectables to treat schizophrenia.
Brooke Kempf, PMHNP
Advertisement
Articles by Brooke Kempf, PMHNP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices
2
Oral Semaglutide Shows Promise for Weight Loss and Cardiometabolic Health
3
FDA Grants Orphan Drug Status to Immunotherapy for Acute Myeloid Leukemia Treatment
4
Modern Therapies Challenge Radiation’s Role in Early Breast Cancer Survival
5
